Healthcare provider profile · identity verified

Sharon E. Joseph, MD

Internal Medicine · POWHATAN, VA · NPI 1659484525

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	513	154
Amlodipine Besylate	Amlodipine Besylate	404	121
Losartan Potassium	Losartan Potassium	311	104
Levothyroxine Sodium	Levothyroxine Sodium	304	78
Rosuvastatin Calcium	Rosuvastatin Calcium	243	78
Omeprazole	Omeprazole	213	61
Metformin Hcl	Metformin Hcl	212	64
Lisinopril	Lisinopril	186	54
Pantoprazole Sodium	Pantoprazole Sodium	163	49
Gabapentin	Gabapentin	159	48
Albuterol Sulfate Hfa	Albuterol Sulfate	148	42
Glipizide	Glipizide	119	27
Metoprolol Succinate	Metoprolol Succinate	117	34
Hydrochlorothiazide	Hydrochlorothiazide	115	37
Ozempic	Semaglutide	113	21
Montelukast Sodium	Montelukast Sodium	112	27
Sertraline Hcl	Sertraline Hcl	109	35
Simvastatin	Simvastatin	106	26
Potassium Chloride	Potassium Chloride	101	27
Carvedilol	Carvedilol	99	29
Furosemide	Furosemide	98	33
Metformin Hcl Er	Metformin Hcl	94	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	93	23
Pravastatin Sodium	Pravastatin Sodium	92	21
Duloxetine Hcl	Duloxetine Hcl	90	22
Trazodone Hcl	Trazodone Hcl	82	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	79	25
Tamsulosin Hcl	Tamsulosin Hcl	79	23
Metoprolol Tartrate	Metoprolol Tartrate	78	23
Trulicity	Dulaglutide	74	15
Glipizide Er	Glipizide	70	15
Tizanidine Hcl	Tizanidine Hcl	69	25
Famotidine	Famotidine	68	18
Synthroid	Levothyroxine Sodium	68	13
Fenofibrate	Fenofibrate	67	23
Alprazolam	Alprazolam	64	13
Citalopram Hbr	Citalopram Hydrobromide	61	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	60	19
Allopurinol	Allopurinol	59	17
Fenofibrate	Fenofibrate Nanocrystallized	59	17
Clopidogrel	Clopidogrel Bisulfate	57	14
Xarelto	Rivaroxaban	55	12
Jardiance	Empagliflozin	52	12
Fluoxetine Hcl	Fluoxetine Hcl	51	14
Alendronate Sodium	Alendronate Sodium	49	suppressed
Hydralazine Hcl	Hydralazine Hcl	49	12
Escitalopram Oxalate	Escitalopram Oxalate	46	12
Fluticasone Propionate	Fluticasone Propionate	46	18
Baclofen	Baclofen	45	11
Buspirone Hcl	Buspirone Hcl	44	17
Warfarin Sodium	Warfarin Sodium	44	suppressed
Spironolactone	Spironolactone	43	12
Chlorthalidone	Chlorthalidone	42	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	14
Pregabalin	Pregabalin	40	11
Atenolol	Atenolol	39	suppressed
Bupropion Xl	Bupropion Hcl	39	16
Eliquis	Apixaban	39	12
Janumet	Sitagliptin Phos/Metformin Hcl	39	suppressed
Ketoconazole	Ketoconazole	39	14
Memantine Hcl	Memantine Hcl	39	suppressed
Azithromycin	Azithromycin	38	34
Vitamin D2	Ergocalciferol (Vitamin D2)	37	15
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Solifenacin Succinate	Solifenacin Succinate	35	suppressed
Mounjaro	Tirzepatide	33	suppressed
Cephalexin	Cephalexin	32	27
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Terazosin Hcl	Terazosin Hcl	32	suppressed
Nystatin	Nystatin	30	16
Benazepril Hcl	Benazepril Hcl	29	suppressed
Meloxicam	Meloxicam	29	suppressed
Glimepiride	Glimepiride	28	suppressed
Mirtazapine	Mirtazapine	28	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Clonazepam	Clonazepam	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Acyclovir	Acyclovir	26	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Myrbetriq	Mirabegron	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Prednisone	Prednisone	25	17
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Irbesartan	Irbesartan	24	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Mupirocin	Mupirocin	24	19
Ondansetron Odt	Ondansetron	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Levetiracetam	Levetiracetam	23	suppressed
Risperidone	Risperidone	23	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Donepezil Hcl	Donepezil Hcl	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Methimazole	Methimazole	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Primidone	Primidone	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Ciclopirox	Ciclopirox	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Victoza 3-Pak	Liraglutide	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Klor-Con M10	Potassium Chloride	13	suppressed
Linzess	Linaclotide	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Estradiol	Estradiol	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Nortrel	Norethindrone-Ethin. Estradiol	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	11	suppressed
Multaq	Dronedarone Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error